Generic Name and Formulations:
Dexrazoxane 500mg; per vial; lyophilized pwd for IV infusion after reconstitution and dilution; preservative-free.
Cumberland Pharmaceuticals, Inc.
Indications for TOTECT:
To treat extravasation resulting from IV anthracycline chemotherapy.
Give once daily for 3 consecutive days by IV infusion over 1–2 hours. Initiate 1st dose as soon as possible and within 1st 6 hours after extravasation. Days 1 and 2: 1000mg/m2; max 2000mg. Day 3: 500mg/m2; max 1000mg. Renal impairment (CrCl <40mL/min): reduce dose by 50%.
Myelosuppression: monitor CBCs. Renal impairment: monitor for hematological toxicity. Hepatic impairment: not recommended. Elderly. Embryo-fetal toxicity. Pregnancy (avoid); exclude status prior to chemotherapy initiation. Use effective contraception during treatment and for 6 months (females) or 3 months (males) after final dose. Nursing mothers: not recommended (during and for 2 weeks after final dose).
Avoid topical dimethylsulfoxide (DMSO). Caution with concurrent cytotoxic chemotherapy (additive cytotoxicity).
Inj site reactions, nausea, vomiting, pyrexia, infections, leukopenia, neutropenia, thrombocytopenia, elevated liver enzymes; hypersensitivity reactions (if severe, consider permanent discontinuation).
Clinical Pain Advisor Articles
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Reducing Mortality After Overdose: Is Treatment for Opioid Use Disorder Effective?
- A Physician's Guide to Incorporating Patient Spirituality in Practice
- Low Literacy Self-Management Program for Chronic Pain May Be Effective
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- The Challenge of Compassion in Modern Healthcare Settings
- Republican Opposition to Obamacare: What's Done, What's to Come
- Steps Taken to Increase Use of Electronic Tools in Medicine
- Daily and Retrospective Pain Measurements Comparable in Hip Osteoarthritis